MedTrace Logo

Non-interventional Study in Pediatric Patients Treated With NOVOCART Inject in the Knee

NCT05391841 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-09-19

No results posted yet for this study

Summary

The study is a prospective, multicenter, single-arm non-interventional study to evaluate the efficacy, safety and health economics of NOVOCART® Inject in the treatment of cartilage defects of the knee in pediatric patients with radiologically proven closed epiphyseal growth plates.

Conditions

  • Cartilage Disease

Interventions

DRUG

NOVOCART Inject

Autologous Chondrocyte Implantation

Sponsors & Collaborators

  • Winicker Norimed GmbH

    collaborator INDUSTRY

  • Tetec AG

    lead INDUSTRY

Principal Investigators

  • Peter Angele, Prof. Dr. · Universitätsklinik Regensburg

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-31
Primary Completion
2029-05-31
Completion
2032-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05391841 on ClinicalTrials.gov